EXPERIENCE & REASON |
a Division of Medical Genetics, Departments of
b Pediatrics
c Human Genetics
j Pathology
d Biochemical Genetics/Nutrition Laboratory, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
e Division of Metabolism and Molecular Pediatrics, University Children's Hospital, Zurich, Switzerland
f Metabolic Unit, University Children's Hospital, Basel, Switzerland
g Department of Pediatrics, Children's Hospital, Braunschweig, Germany
h Departments of Laboratory Medicine and Pathology, Pediatric and Adolescent Medicine and Medical Genetics, Mayo Clinic College of Medicine, Rochester, Minnesota
i Biochemical Genetics Laboratory, University of California at San Diego, La Jolla, California
ABSTRACT
We report 2 patients with isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency whose urine was devoid of, or contained only trace, 3-methylcrotonylglycine, the pathognomonic marker for this disorder. The first patient, a girl with trisomy 21, was detected through newborn screening with an elevated 5 carbon hydroxycarnitine species level, and the second patient came to clinical attention at the age of 5 months because of failure to thrive and developmental delay. Investigation of urinary organic acids revealed an elevated 3-hydroxyisovaleric acid level but no demonstrable 3-methylcrotonylglycine in both patients. Enzyme studies in cultured fibroblasts confirmed isolated 3-methylcrotonyl-coenzyme A carboxylase deficiency with residual activities of 5% to 7% and 12% of the median control value, respectively. Incorporation of 14C-isovaleric acid into intact fibroblasts was essentially normal, showing that the overall pathway was at least partially functional and potentially explaining the absence of 3-methylcrotonylglycine in urine. Mutation analysis of the MCCA and MCCB genes revealed that both patients were compound heterozygous for a missense mutation, MCCB-c.1015G
A (p.V339M), and a second mutation that leads to undetectable MCCB messenger (poly A+) RNA. Absent or trace 3-methylcrotonylglycine levels in urine raises the potential for misdiagnosis in the clinical biochemical genetics laboratory based solely on urine organic acid analysis using combined gas chromatography-mass spectrometry.
Key Words: 3-methylcrotonyl-coenzyme A carboxylase deficiency 3-MCC 3-methylcrotonylglycinuria 3-MCG 3-hydroxyisovaleric acid 3-HIVA C5-hydroxylacylcarnitine C5-OH carnitine newborn screening tandem mass spectrometry organic acids
Abbreviations: CoA, coenzyme A 3-MCC, 3-methylcrotonyl-coenzyme A carboxylase 3-HIVA, 3-hydroxyisovaleric acid 3-MCG, 3-methylcrotonylglycine MCCA (MCC
/MCCC1), 3-methylcrotonyl-coenzyme A carboxylase
subunit MCCB (MCCβ/MCCC2), 3-methylcrotonyl-coenzyme A carboxylase β subunit C5-OH carnitine, 5 carbon hydroxycarnitine species MCD, multiple carboxylase deficiency PCC, propionyl-coenzyme A carboxylase PCR, polymerase chain reaction mRNA, messenger (poly A+) RNA HMG-CoA lyase, 3-hydroxy-3-methylglutaryl-coenzyme A lyase 3-MGA, 3-methylglutaconic aciduria